...
首页> 外文期刊>Clinical Interventions in Aging >The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart?failure
【24h】

The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart?failure

机译:N端前B型利钠肽对中国老年人慢性心力衰竭的预测能力和附加预后能力

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: This study was conducted to research the prognostic utility of N-terminal pro-B-type natriuretic peptide (NT-proBNP), compare the utility of the Seattle Heart Failure Score (SHFS) with NT-proBNP, develop a risk-evaluation model based on NT-proBNP, assess the associations of NT-proBNP with patient characteristics, and screen for decisive factors of NT-proBNP in Chinese elderly with chronic heart failure (CHF).Patients and methods: There were 306 patients (≥60 years) with CHF chosen as study subjects. Each one received an assessment of NT-proBNP on serum. The end point was all-cause mortality during a mean follow-up period of 471 days.Results: Subjects had a median age of 85 (60–100) years, a median NT-proBNP of 1,743.4 pg/mL, and a median SHFS of 1.87. During the follow-up period, 104 deaths occurred. NT-proBNP was significantly related to mortality (odds ratio 1.603, 95% confidence interval 1.407–1.826; P<0.001) and the significance persisted after full adjustment (odds ratio 1.282, 95% confidence interval 1.103–1.489; P=0.001). Age, New York Heart Association class IV CHF, plasma albumin, and neutrophils/lymphocytes were also independent predictors for mortality (P<0.05 for all). NT-proBNP and the SHFS showed similar predictive capacities (0.736 versus 0.796, P=0.105). The addition of NT-proBNP to the SHFS (0.818 versus 0.796, P=0.168) generated marginal growth in the c-statistic. The model based on NT-proBNP consisting of all selected predictors in this study, including age, New York Heart Association class IV CHF, plasma albumin, neutrophils/lymphocytes, and NT-proBNP, had a moderately higher c-statistic compared with the SHFS (0.846 versus 0.796, P=0.066). NT-proBNP was bound with the SHFS (r=0.500, P<0.001). Characteristics regarding general condition, inflammation, and cardiac and renal function were the decisive factors of NT-proBNP (P<0.05 for all).Conclusion: As a comprehensive representation of the patient characteristics described earlier, NT-proBNP values provided significant prognostic power similar to the SHFS in Chinese elderly with CHF. A novel model based on NT-proBNP could offer help for risk stratification.
机译:目的:本研究旨在研究N末端pro-B型利钠肽(NT-proBNP)的预后作用,比较西雅图心力衰竭评分(SHFS)和NT-proBNP的作用,进行风险评估以NT-proBNP为基础的模型,评估NT-proBNP与患者特征的相关性,并筛选中国老年慢性心力衰竭(CHF)患者NT-proBNP的决定性因素。方法与方法:306例(≥60岁)患者),并选择瑞士法郎作为研究对象。每个人接受血清NT-proBNP的评估。终点是平均随访期471天的全因死亡率。结果:受试者的中位年龄为85(60–100)岁,中位NT-proBNP中位值为1,743.4 pg / mL,中位SHFS 1.87。在随访期间,有104人死亡。 NT-proBNP与死亡率显着相关(赔率1.603,95%置信区间1.407-1.826; P <0.001),其显着性在完全调整后仍然存在(赔率1.282,95%置信区间1.103-1.489; P = 0.001)。年龄,纽约心脏协会IV级CHF,血浆白蛋白和中性粒细胞/淋巴细胞也是死亡率的独立预测因子(所有患者的P <0.05)。 NT-proBNP和SHFS显示相似的预测能力(0.736对0.796,P = 0.105)。向SHFS中添加NT-proBNP(0.818对0.796,P = 0.168)在c统计量中产生了边际增长。基于NT-proBNP的模型由本研究中所有选定的预测因子组成,包括年龄,纽约心脏协会IV级CHF,血浆白蛋白,中性粒细胞/淋巴细胞和NT-proBNP,与SHFS相比,其c统计量略高(0.846对0.796,P = 0.066)。 NT-proBNP与SHFS结合(r = 0.500,P <0.001)。有关一般状况,炎症以及心脏和肾功能的特征是NT-proBNP的决定性因素(所有P均<0.05)。结论:作为较早描述的患者特征的全面表现,NT-proBNP值提供了显着的预后能力CHF对中国老年人CHF的影响。基于NT-proBNP的新型模型可以为风险分层提供帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号